Project Details
Description
A Multi-Center Randomized double blind placebo controlled trial to evaluate the safety and efficacy of inhaled treprostinil in subjects with pulmonary hypertension due to parenchymal lung disease
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/16 → 10/30/21 |
Funding
- United Therapeutics Corporation
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.